two disparate regions of the genome and the hallmark of any structural variant (SV). However, although this approach can be readily used for the analysis of tumor tissue (in which somSVs are clonally amplified and therefore present in all or most of the cells), it cannot be applied for the detection of ultra-low-abundant somSVs, which typically affect only one sequencing read in normal, non-clonal tissue. Here we present SVS for the quantitative detection of somSVs by ultra-low-coverage sequencing.
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The key feature of SVS is its ability to definitively call an SV using a single sequencing read that spans the breakpoint, without the need for multiple supporting reads. Such high-confidence calling of SVs is achieved in two critical steps: a chimera-free library preparation protocol and application of a novel, nonconsensus-based SV-calling algorithm (http://www.einstein. yu.edu/docs/faculty/profiles/11319-alexander-maslov/svs.zip; Supplementary Software). Chimeras, which result from the erroneous concatenation of two genomic fragments during adaptor ligation, occur as unique events throughout the sequencing reads and are normally discarded on the basis of an absence of alternative reads covering the same breakpoint. SomSVs, however, are spread across the reads as unique events and cannot be distinguished from ligation artifacts. As a method of choice in SVS, we use MuPlus, our modification of a transposon-based protocol for the preparation of barcoded sequencing libraries, which is free of ligationmediated artifacts 11 .
Our SV-calling algorithm consists of three steps: (1) identification of potential SVs via a split-read approach 12 , (2) filtering out of potential technical and mapping artifacts, and (3) separation of somatic and germline SVs on the basis of identification of the latter as identical variants repetitively found in independently prepared sequencing libraries (Online Methods and Fig. 1) .
To evaluate the specificity and sensitivity of SVS, we used the CaSki cell line, harboring 47 human papillomavirus (HPV) integration events 13 , which are in essence SVs. SVS analysis of CaSki DNA revealed 20 distinct HPV integration sites (Supplementary Tables 1 and 2), 17 (85%) of which were previously described 13 . We tested the remaining three by PCR and found two of them to be genuine ( Supplementary Fig. 1 ). Most likely these two HPV integration sites had not been detected previously because of their low abundance, underscoring the unique capability of SVS to detect low-frequency SVs. Thus, this experiment demonstrated 95% specificity and 36.2% sensitivity of SVS in the detection of SVs.
Further, we estimated the lower limit for SV loads measurable by SVS. Assuming that the CaSki line is completely homogeneous with no subclonal variation, it can be considered as a model system in which every cell has 47 SVs (23.5 SVs per haploid genome). We found ~2.83 HPV integration sites per library after sequencing Genome analysis by high-throughput sequencing (HTP-seq) has provided extensive data sets of germline variants in the human and other genomes, as well as detailed information on thousands of somatic mutations in human tumors [1] [2] [3] . However, almost no information is available on somatic mutation frequencies and mutation spectra in normal cells and tissues. This is due to the nature of somatic mutations, which are typically unique in each cell and virtually indistinguishable from the considerable amount of errors associated with every step of HTP-seq, from library preparation to sequencing, sequence alignment, and variant calling 4, 5 . Several approaches have been developed for the detection of somatic base-pair substitutions and small insertions and/or deletions [6] [7] [8] [9] , but the same is not true for somSVs such as large deletions, insertions, inversions, and translocations 5 . Existing computational algorithms for the detection of somSVs in HTP-seq data sets, such as CREST 10 , rely on the validation of any variant call by multiple independent supporting sequencing reads spanning the same DNA breakpoint, the junction between 12 independent libraries, each of which was covering ~28% of the genome ( Supplementary Table 1 ). This is less than the expected 6.58 (23.5 × 0.28) sites per library, presumably because of the heterogeneity of the CaSki cell line and the low-coverage sequencing used. Indeed, examination of expected but not found HPV integration sites revealed no breakpoints. Thus, SVS is capable of detecting 47 somSVs per cell using ~0.3× sequencing.
Quantitative detection of low-abundance somatic structural variants in normal cells by highthroughput sequencing
Next, to empirically validate SVS for its capacity to detect somSVs, we treated human IMR90 fibroblasts with two different clastogens, bleomycin and etoposide, applied at three different concentrations. We collected samples at 72 h and immediately after treatment, and we sequenced MuPlus libraries on the Ion Proton platform, with 6-12 samples multiplexed on each sequencing run. All identified interchromosomal and intrachromosomal rearrangements (larger than 200 nt to avoid possible polymerase slippage 14 and homopolymer artifacts) were considered for further analysis ( Supplementary Table 3 ). SVs found in at least two independent samples were counted as germline SVs. Of note, the number of germline SVs reached a plateau after analysis of ~50 DNA samples (accumulated coverage: ~17×) out of a total of 70 (i.e., at ~4,000 detected total SVs; Fig. 2a) , indicating that the majority of germline variants had been discovered. After correction for germline SVs, we observed a statistically significant dosedependent increase in SV frequency in samples collected 72 h after genotoxic insult ( Fig. 2b and Supplementary Fig. 2a) .
SVs arise as a consequence of erroneous processing of DNA double-strand breaks (DSBs) induced by clastogens, probably within hours after the beginning of treatment 15 . The SVs detected could represent artifacts generated during library preparation and/or sequencing due to the presence of damaged DNA fragments. Reasoning that such damage should be at a maximum immediately after treatment, we tested for SVs immediately after 6 h of treatment with bleomycin or etoposide. The results indicated an increased number of SVs after treatment with bleomycin, but not etoposide (except at the highest concentration) ( Fig. 2c and Supplementary Fig. 2b) . Whereas bleomycin is a DNA-cleaving agent capable of creating DSBs available for repair immediately upon exposure 16 , etoposide is a topoisomerase II poison that stabilizes the DNA-enzyme complex and initially creates single-strand breaks 17 , which can later be transformed into DSBs. Thus the increased number of SVs after 6 h of treatment with bleomycin can be explained by the early emergence of errors during DNA DSB repair within this time period.
Because of the unique nature of somSVs, it is not possible to confirm them independently. However, data for most germline SVs can be found in databases, and therefore they can function as internal positive controls. We found that 925 out of 1,012 germline SVs in the IMR90 cells (91.4%) ( Supplementary Table 4 ) are listed in the available database of human SVs (ftp://ftp.ncbi.nlm. nih.gov/pub/dbVar/data/Homo_sapiens/). We tested the remaining 87 using size separation after PCR with SV-specific primer pairs. We confirmed 17 out of 18 germline interchromosomal rearrangements (94.4%) and 66 out of 69 intrachromosomal SVs (95.6%) specific for this particular cell line ( Supplementary Fig. 3 and Supplementary Table 5 ). Of note, only 3.7% of SVs identified by SVS as somatic were found in the database and were therefore false positives. Analysis for the presence of microhomology (MH) (5 nt or larger) at the junction points of the SVs showed that whereas germline SVs and background SVs have approximately equal fractions of rearrangements containing MH (1.8% and 1.4%, respectively), the bleomycin-and etoposide-induced SVs were substantially enriched for MH (4.9% and 3.9%, respectively; Supplementary  Fig. 4 ). This suggests that MH-mediated end joining is involved in the repair of clastogen-induced DNA DSBs. Next, we analyzed the relative distance between observed SVs and centrosomes of corresponding chromosomes and found that breakpoints were distributed evenly along the chromosomes (Supplementary Fig. 5 ). Finally, we analyzed the distribution of SV breakpoints across different genomic features and found that somSVs had an ~2.5× higher probability of residing in transcription factor binding sites and exonic regions than germline SVs did ( Supplementary  Fig. 6a,b) . We found a similar distribution of germline SVs and somSVs for DNase-sensitive sites (Supplementary Fig. 6c ). Further analysis showed that germline SVs were depleted from functionally active genomic regions, whereas the frequency of somSVs in these regions was higher (~66% on average) than would be expected with a random distribution ( Supplementary  Fig. 6d ). This suggests that although euchromatic regions of the genome are generally more prone to DNA breakage, the germline SVs, unlike somSVs, are under selective pressure that eliminates variants with negative functional consequences.
Further analysis of SV spectra revealed that the fraction of intrachromosomal rearrangements for bleomycin was substantially smaller than for etoposide (22% and 39% of all SVs, respectively; Fig. 2d ). Among intrachromosomal rearrangements, the fraction of inversions was substantially higher for etoposide than for bleomycin (45% and 30%, respectively; Supplementary Fig. 7) . This preferential production of translocations by bleomycin and of inversions by etoposide may reflect different mechanisms of action for these two clastogens. Notably, the frequency of germline SVs was approximately equal in all tested samples-both control and clastogen-treated ( Supplementary Fig. 8 ). We found that 69% of somSVs in control, nontreated samples were interchromosomal rearrangements, compared with 2% of germline SVs (Fig. 2e) . This is in agreement with findings by others in studies comparing SVs in tumor with germline SVs 18 .
The SVS assay is cost-effective, as it does not require highcoverage sequencing, and it should enable the characterization of tissue-and age-specific landscapes of SVs in humans and experimental animals. Of note, the assay should also be applicable as a routine genetic toxicology tool to assess the clastogenicity of new drugs and chemicals. Finally, SVS will be useful for assessing genome instability as a biomarker in aging and disease.
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